English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Amgen Inc.
Press release submission
| Dec 20, 2021
FDA Approves Otezla® (Apremilast) for the Treatment of Adult Patients With Plaque Psoriasis, Regardless of Severity Level
Press release submission
| Sep 5, 2021
New Tezepelumab Data Show 86% Reduction In Exacerbations In Patients With Severe Asthma And Comorbid Nasal Polyps
Press release submission
| Mar 15, 2019
AMGEN, INC.: Announces New Four-Year Outcomes Study To Examine Long-Term Effects Of Repatha® (evolocumab) In High-Risk Cardiovascular Disease (CVD) Patients Without Prior Heart Attack Or Stroke
Carol Ostrow
| Dec 15, 2017
Amgen Foundation commits $500,000 to help southern California wildfire victims
Carol Ostrow
| Dec 10, 2017
Amgen's Repatha wins FDA approval
Carol Ostrow
| Dec 8, 2017
Amgen presents at Evercore conference
Mark Iandolo
| Nov 1, 2017
Cancer information awareness campaign features conversations with Joan Lunden
Kathy Adams
| Oct 22, 2017
Amgen, Boston Children's Hospital team up for study on unusual pain response
Trending
+
Pharmaceuticals
Patient Daily
| Nov 21, 2024
Las Olas Wine & Food Festival set for April; ticket sales begin Black Friday
+
Pharmaceuticals
Patient Daily
| Nov 15, 2024
Charlotte event raises $110k for lung cancer fight
+
Community
Patient Daily
| Nov 19, 2024
Babylon Dental Care Associate Dentist Absatz: ‘Older adults should follow the same dental care guidelines as anyone else’
+
Pharmaceuticals
Patient Daily
| Nov 19, 2024
Surgeon General's new report targets persistent health disparities linked to tobacco
1
2
3
»
Last »